UBS Group AG - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 57 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2017$33,000
-23.3%
73,903
-13.3%
0.00%
Q3 2016$43,000
+330.0%
85,191
+731.1%
0.00%
Q2 2016$10,000
+233.3%
10,250
+120.7%
0.00%
Q1 2016$3,000
-85.7%
4,645
-73.6%
0.00%
Q4 2015$21,000
-40.0%
17,575
+10.5%
0.00%
Q3 2015$35,000
+1066.7%
15,900
+1122.1%
0.00%
Q2 2015$3,0001,301
+4718.5%
0.00%
Q1 2015$0
-100.0%
27
-99.1%
0.00%
Q4 2014$7,0003,0520.00%
Other shareholders

There were no reported owners of ONCOGENEX PHARMACEUTICALS IN in Q1 2015.

NameSharesValueWeighting ↓
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders